Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
106.93
(
0.00%
)
Bitcoin
70,614.00
(
0.14%
)
News Focus
News Focus

Replies to post #68820 on Biotech Values

Replies to #68820 on Biotech Values
icon url

genisi

11/21/08 12:56 PM

#68846 RE: DewDiligence #68820

Just to note that Promacta is also being studied in phase III for thrombocytopenia associated with chronic HCV, chronic liver disease and oncology-related thrombocytopenia in phase I.